Versant Capital Management’s Acceleron Pharma XLRN Stock Holding History

Versant Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-57	Closed	-$10K	–	1650
2021 Q3	$10K	Buy	57 +25	+78%	+$3.27K	﹤0.01%	714
2021 Q2	$4K	Buy	32 +15	+88%	+$1.89K	﹤0.01%	1011
2021 Q1	$2K	Buy	+17	New	+$2.2K	﹤0.01%	1297

Versant Capital Management's XLRN Position: Q4 2021 in Review

Versant Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 57 shares — an estimated $10K sold.

Versant Capital Management first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $10K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Versant Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Versant Capital Management sold 57 Acceleron Pharma shares in Q4 2021, an estimated $10K.
Versant Capital Management first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
Versant Capital Management's Acceleron Pharma position peaked at $10K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Versant Capital Management's 13F filing for Q4 2021, filed 6 Jan 2022.